SciSparc Ltd. (SPRC)Healthcare | Biotechnology | Tel Aviv-Yafo, Israel | NasdaqCM
4.57 USD
-0.13
(-2.766%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 4.55 -0.02 (-0.020%) ⇩ (July 13, 2026, 6:23 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:27 a.m. EDT
The immediate outlook is severely clouded by a relentless multi-year price collapse and deteriorating fundamentals. While the company recently announced a significant acquisition by its subsidiary NeuroThera, the stock has lost nearly 99.5% of its value over the last three years, with every single year showing double-digit declines. This consistent downward trajectory suggests the market views the business quality as fundamentally broken, regardless of the latest headlines. Compounding this distress is a massive gap between the current share price and the book value of $11.60, indicating the market is pricing in total insolvency or a complete loss of equity value. Furthermore, the company is burning cash with negative operating cash flow and negative returns on both assets and equity. There is no dividend to provide any income cushion, and the recent trading pattern shows continued weakness despite the acquisition news. The statistical models also lean negative for the coming month, reinforcing the view that the recent volatility has not yet reversed the long-term downtrend. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.283674 |
| AutoARIMA | 0.283797 |
| AutoETS | 0.283798 |
| AutoTheta | 0.321107 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 0.47 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.172 |
| Excess Kurtosis | -1.19 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 7.111 |
| Revenue per Share | 6.893 |
| Market Cap | 2,619,720 |
| Trailing P/E | 0.05 |
| Beta | 2.48 |
| Previous Name | Therapix Biosciences Ltd. |
| Website | https://scisparc.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9321789 |
| Address1 | Tower A |
| Address2 | 2nd Floor 20 Raul Wallenberg Street |
| All Time High | 41,769.0 |
| All Time Low | 0.0 |
| Ask | 5.46 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 56,050 |
| Average Daily Volume3 Month | 1,108,873 |
| Average Volume | 1,108,873 |
| Average Volume10Days | 56,050 |
| Beta | 2.483 |
| Bid | 3.42 |
| Bid Size | 2 |
| Book Value | 11.6 |
| City | Tel Aviv-Yafo |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.57 |
| Current Ratio | 2.413 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 4.855 |
| Day Low | 4.23 |
| Debt To Equity | 7.111 |
| Display Name | SciSparc |
| Earnings Timestamp End | 1,745,524,800 |
| Earnings Timestamp Start | 1,745,524,800 |
| Ebitda | -8,528,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.082 |
| Enterprise To Revenue | -0.815 |
| Enterprise Value | -697,279 |
| Eps Trailing Twelve Months | 98.07 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.88112 |
| Fifty Day Average Change | -2.31112 |
| Fifty Day Average Change Percent | -0.33586392 |
| Fifty Two Week Change Percent | -93.21789 |
| Fifty Two Week High | 80.1 |
| Fifty Two Week High Change | -75.53 |
| Fifty Two Week High Change Percent | -0.9429463 |
| Fifty Two Week Low | 2.98 |
| Fifty Two Week Low Change | 1.5900002 |
| Fifty Two Week Low Change Percent | 0.5335571 |
| Fifty Two Week Range | 2.98 - 80.1 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,630,330,200,000 |
| Float Shares | 553,392 |
| Free Cashflow | 833,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 3 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.73714995 |
| Gross Profits | 631,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.0054900004 |
| Implied Shares Outstanding | 573,243 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-12-22 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,772,582,400 |
| Last Split Factor | 1:9 |
| Long Business Summary | SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral tablets CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. |
| Long Name | SciSparc Ltd. |
| Market | us_market |
| Market Cap | 2,619,720 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_23813054 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -12,179,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,694,242 |
| Open | 4.7 |
| Operating Cashflow | -4,137,000 |
| Operating Margins | -8.48949 |
| Payout Ratio | 0.0 |
| Phone | 972 7 334 47180 |
| Post Market Change | -0.01999998 |
| Post Market Change Percent | -0.43763632 |
| Post Market Price | 4.55 |
| Post Market Time | 1,783,981,411 |
| Prev Name | Therapix Biosciences Ltd. |
| Previous Close | 4.7 |
| Price Hint | 4 |
| Price To Book | 0.3939655 |
| Price To Sales Trailing12 Months | 3.0604205 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.131 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -2.76595 |
| Regular Market Day High | 4.855 |
| Regular Market Day Low | 4.23 |
| Regular Market Day Range | 4.23 - 4.855 |
| Regular Market Open | 4.7 |
| Regular Market Previous Close | 4.7 |
| Regular Market Price | 4.57 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 38,623 |
| Return On Assets | -0.60681 |
| Return On Equity | -1.7839 |
| Revenue Growth | -0.345 |
| Revenue Per Share | 6.893 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 573,243 |
| Shares Percent Shares Out | 0.045500003 |
| Shares Short | 26,064 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 378,196 |
| Short Name | SciSparc Ltd. |
| Short Percent Of Float | 0.045500003 |
| Short Ratio | 0.05 |
| Source Interval | 15 |
| Symbol | SPRC |
| Total Cash | 4,591,000 |
| Total Cash Per Share | 8.009 |
| Total Debt | 366,000 |
| Total Revenue | 856,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 98.07 |
| Trailing P E | 0.04659937 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 13.656505 |
| Two Hundred Day Average Change | -9.086504 |
| Two Hundred Day Average Change Percent | -0.66536087 |
| Type Disp | Equity |
| Volume | 38,623 |
| Website | https://scisparc.com |
| Zip | 6,971,916 |